RX694 RX694 Pill - white capsule/oblong, 14mm
Pill with imprint RX694 RX694 is White, Capsule/Oblong and has been identified as Minocycline Hydrochloride 50 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bullous Pemphigoid; Bartonellosis; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RX694 RX694




Minocycline Hydrochloride
- Imprint
- RX694 RX694
- Strength
- 50 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
-
gelatin,
titanium dioxide,
propylene glycol,
shellac,
potassium hydroxide,
corn starch,
ferrosoferric oxide,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
13668-0482 | Torrent Pharmaceuticals Limited |
63304-0694 | Ranbaxy Pharmaceuticals Inc. |
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Dynacin, Ximino, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Emrosi, Minocin for Injection, Ximino, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.